EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marc Riquet
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riquet, M.
Right arrow Articles by Foucault, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riquet, M.
Right arrow Articles by Foucault, C.
Related Collections
Right arrow Lung - cancer

Eur J Cardiothorac Surg 2007;31:141. doi:10.1016/j.ejcts.2006.10.027
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved


Letters to the Editor

Pulmonary resection in octogenarians

Marc Riquet*, Pascal Berna, Joao-Carlos das Neves-Pereira, Christophe Foucault

Georges Pompidou European Hospital, 20 rue Leblanc, 75015 Paris, France

Received 8 October 2006; accepted 25 October 2006.

* Corresponding author. Tel.: +33 1 56 09 34 50. (Email: marc.riquet@hop.egp.ap-hop-paris.fr).

Key Words: Octogenarians • Pneumonectomy • TNM

The first 20% of the full text of this article appears below.

The experience of Matsuoka et al. [1] with resections for lung cancer in octogenarians (n = 40) was characterised by 20% non-lethal complications (n = 8), 40% lobectomies (n = 16), 60% segmentectomies and wedge (n = 12 each), no pneumonectomy. There were 22 adenocarcinomas (55%), 11 squamous (27.5%), 4 large-cell (10%), 2 adenosquamous (5%), 1 neuroendocrine (2.5%) cell carcinomas and essentially pStage I disease (n = 35, 87.5%; pStage II n = 3, 7.5% and . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Matsuoka
Reply to Riquet et al.
Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 141 - 141.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Shanmugam
Reply to Riquet et al.
Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 142 - 142.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.